Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01579370 · ClinicalTrials.gov registry record · NA
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A NA study of Healthcare Associated Infections and Multidrug Resistant Organisms, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 21,395
- Enrollment target
- 9
- Study locations
NCT01579370: Completed NA study of Healthcare Associated Infections and Multidrug Resistant Organisms, sponsored by Duke University.
NCT01579370 is a NA study of Healthcare Associated Infections and Multidrug Resistant Organisms that has completed, run by Duke University. The registered enrollment target is 21,395 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1425% higher). The trial reports 9 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01579370, a NA study of Healthcare Associated Infections and Multidrug Resistant Organisms, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21,395 participants
- Enrollment target
- 9
- Study locations
Study Summary
Enhanced terminal room disinfection is a novel, promising, but still unproven strategy for the prevention of healthcare-associated infections (HAIs) due to selected multidrug-resistant (MDR) bacterial pathogens. The investigators will perform a large prospective, multicenter study enhanced terminal room disinfection to 1) determine the efficacy and feasibility of enhanced terminal room disinfection strategies to prevent HAIs and 2) determine the impact of environmental contamination on acquisition of MDR-pathogens among hospitalized patients.
Primary Outcome
Patients will be monitored for clinical cultures that grow one of four target organisms (MRSA, VRE, C. difficile, and MDR-Acinetobacter) following admission to a "seed" room. Cultures for vegetative bacteria (MRSA, VRE, Acinetobacter) will be included if obtained within 90 days of discharge from a seed room; cultures for C. difficile will be included if they are obtained within 28 days of discharge from a seed room.
Conditions Studied
Interventions
- OTHER Quaternary ammonium
- OTHER Bleach
- OTHER Quaternary ammonium and UV-C light
- OTHER Bleach and UV-C light
Study Locations (9)
North Carolina
- Alamance Regional Medical Center - Burlington
- University of North Carolina Hospitals - Chapel Hill
- Durham Regional Hospital - Durham
- Duke University Medical Center - Durham
- Durham VA Medical Center - Durham
- High Point Regional Health System - High Point
- Rex Healthcare - Raleigh
- Duke Raleigh Hospital - Raleigh
Virginia
- Chesapeake Regional Medical Center - Chesapeake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,395 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT01579370 record still lists
NCT01579370 is an interventional study that assigns participants to a tested intervention. Its 21,395 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1425% higher).
The record links to 2 conditions, with Healthcare Associated Infections appearing as the primary indexed condition, and to 4 interventions - of which Quaternary ammonium is the first listed.
NCT01579370 lists 9 locations in 2 states (North Carolina, Virginia).
Frequently Asked Questions
What is clinical trial NCT01579370 about?
NCT01579370 is a clinical study titled "Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)". Enhanced terminal room disinfection is a novel, promising, but still unproven strategy for the prevention of healthcare-associated infections (HAIs) due to selected multidrug-resistant (MDR) bacterial pathogens. The investigators will perform a large prospective, multicenter study enhanced terminal ...
What is the current status of trial NCT01579370?
This trial is currently completed. It is a NA study. The enrollment target is 21,395 participants. The study started on 2012-04. Estimated completion is 2015-08.
What conditions does trial NCT01579370 study?
This clinical trial studies the following conditions: Healthcare Associated Infections, Multidrug Resistant Organisms.
What interventions are being tested in trial NCT01579370?
The interventions under investigation include: Quaternary ammonium (OTHER), Bleach (OTHER), Quaternary ammonium and UV-C light (OTHER), Bleach and UV-C light (OTHER).
Who is sponsoring clinical trial NCT01579370?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01579370 being conducted?
This trial has 9 study locations across North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthcare Associated Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01579370's enrollment target sits among peer trials
21,395 10th of 2000 higher than 1,991 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06047041 · 21,350 participants · NA
Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
- NCT07213531 · 21,000 participants
Enhanced Valves Interventions and Safe AI Generated End Results
- NCT05832307 · 22,000 participants · NA
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
- NCT05488080 · 22,032 participants · NA
PAINED: Project Addressing INequities in the Emergency Department
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia